Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

VYNE

VYNE Therapeutics (VYNE)

VYNE Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VYNE
DataHoraFonteTítuloCódigoCompanhia
23/01/202518:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
13/01/202509:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
19/12/202418:27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VYNEVYNE Therapeutics Inc
14/11/202417:34Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VYNEVYNE Therapeutics Inc
12/11/202418:06Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:VYNEVYNE Therapeutics Inc
12/11/202418:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VYNEVYNE Therapeutics Inc
07/11/202418:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VYNEVYNE Therapeutics Inc
01/03/202419:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VYNEVYNE Therapeutics Inc
02/02/202411:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VYNEVYNE Therapeutics Inc
03/01/202419:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
24/11/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VYNEVYNE Therapeutics Inc
22/11/202318:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VYNEVYNE Therapeutics Inc
16/11/202318:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VYNEVYNE Therapeutics Inc
13/11/202318:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VYNEVYNE Therapeutics Inc
02/06/202317:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VYNEVYNE Therapeutics Inc
11/05/202317:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VYNEVYNE Therapeutics Inc
11/05/202317:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VYNEVYNE Therapeutics Inc
14/03/202318:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VYNEVYNE Therapeutics Inc
10/01/202310:45AllPennyStocks.comBiotech Catches Major Premarket BidNASDAQ:VYNEVYNE Therapeutics Inc
25/11/202216:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VYNEVYNE Therapeutics Inc
18/11/202219:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:VYNEVYNE Therapeutics Inc
14/11/202218:51Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:VYNEVYNE Therapeutics Inc
11/11/202208:25TipRanksVYNE Therapeutics (VYNE) Gets a Buy from H.C. WainwrightNASDAQ:VYNEVYNE Therapeutics Inc
10/08/202211:10TipRanksAnalysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and MiNK Therapeutics (INKT)NASDAQ:VYNEVYNE Therapeutics Inc
28/07/202217:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VYNEVYNE Therapeutics Inc
21/06/202206:06TipRanksLifeSci Capital Thinks VYNE Therapeutics’ Stock is Going to RecoverNASDAQ:VYNEVYNE Therapeutics Inc
19/06/202204:50TipRanksVYNE Therapeutics (VYNE) Gets a Buy Rating from H.C. WainwrightNASDAQ:VYNEVYNE Therapeutics Inc
24/05/202205:15TipRanksAnalysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and Nano-X Imaging (NNOX)NASDAQ:VYNEVYNE Therapeutics Inc
20/05/202206:01TipRanksAnalysts Offer Insights on Healthcare Companies: and VYNE Therapeutics (VYNE)NASDAQ:VYNEVYNE Therapeutics Inc
18/05/202207:18TipRanksH.C. Wainwright Thinks VYNE Therapeutics’ Stock is Going to RecoverNASDAQ:VYNEVYNE Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:VYNE